A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Immature platelets in patients hospitalized with Covid-19
2020
Journal of Thrombosis and Thrombolysis
Coronavirus disease 2019 (Covid-19) is associated with high incidence of venous and arterial thromboembolic events. Currently, there are no markers to guide antithrombotic therapy in Covid-19. Immature platelets represent a population of hyper-reactive platelets associated with arterial events. This prospective study compared consecutive Covid-19 patients (n = 47, median age = 56 years) to patients with acute myocardial infarction (AMI, n = 100, median age = 59 years) and a group of stable
doi:10.1007/s11239-020-02290-6
pmid:32997333
pmcid:PMC7526077
fatcat:zzenwisu7fcdzdwguqtoflczem